According to Galmed Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$0.04 B. In 2020 the company made an earning of -$0.04 B a decrease over its 2019 earnings that were of -$0.03 B. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2021 (TTM) | -$0.04 B | 18.28% |
2020 | -$0.04 B | 35.01% |
2019 | -$0.03 B | 108.83% |
2018 | -$0.02 B | -13.34% |
2017 | -$0.02 B | -26.76% |
2016 | -$0.02 B | 55.24% |
2015 | -$0.02 B | 18.96% |
2014 | -$9.15 M | -37.22% |
2013 | -$0.02 B |